comparemela.com

Latest Breaking News On - Phouman ashrafian - Page 1 : comparemela.com

Sanofi releases new data for innovative oral asthma treatment

New findings from a Sanofi trial highlight promise for the potential first advanced oral treatment for moderate-to-severe asthma.

United statesTanya laidlawPhouman ashrafianTranslational research in allergy brighamAmerican thoracic societyHead of researchInternational conferenceSanofi phaseThoracic societyTranslational researchAllergy brighamVice president

Phase 2 Study Demonstrates Oral Rilzabrutinib Reduces Loss of Control Events in Patients With Asthma

According to the investigators, these findings support the investigation of rilzabrutinib in patients with asthma in a phase 3 trial program.

San diegoUnited statesTanyam laidlawPhouman ashrafianTranslational research in allergyAmerican thoracic society international conferenceThoracic society international conferenceConcept studyAdult participants with moderate to severeTranslational researchAsthma controlMedia updatePress release

Sanofi CSO Frank Nestle is leaving

Sanofi CSO Frank Nestle is leaving
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomPhouman ashrafianPaul hudsonKing college of londonCare researchUs national institutes of healthUk national institute of healthHead of research frank nestleSanofi chief scientific officerResearch frank nestleFierce biotechBay areaSenior investigator emeritus

Hematology Month in Review: April 2024

Our April month in review for hematology breaks down the latest updates to the pipeline, mortality risk in people with sickle cell disease, and our newest multimedia offerings.

Phouman ashrafianElna saahAmerican gastrointestiological associationEmory university school of medicineEmory university school

Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript

Sanofi reports earnings inline with expectations. Reported EPS is $0.96 EPS, expectations were $0.96.

San diegoUnited statesPeter welfordPhouman ashrafianLuisa hectorXavier rogerBrian foardPaul hudsonThomas triompheGraham parryResearch your family historySarclisa groupConsumer healthQuadruple ai congressMinistries of healthUnidentified company representative

vimarsana © 2020. All Rights Reserved.